AstraZeneca announced an agreement to acquire TeneoTwo, Inc., including its phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma...
Serum Institute has requested the Union health ministry for inclusion of their Cy-Tb injection for detection of Latent-TB in the National TB Elimination Programme (NTEP) to support TB free-India by 2025, official sources said...
French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step of its plan to increase access to its medicines worldwide....
Public health experts are calling for more transparency in the drug approval system and the overall drug regulatory framework in the country, in the wake of the recent episode in which the Central Bureau of Investigation (CBI)...
How are players getting into new geographies & developing innovative products to succeed in the growing competitive veterinary medicine market.
US health officials said they have agreed to purchase another 105 million doses of Pfizer's COVID-19 vaccine in anticipation of a fall booster campaign...
Eli Lilly to supply additional doses of COVID antibody drug to U.S.Eli Lilly and Co said on Wednesday it will supply additional doses of its COVID-19 antibody drug to the U.S. government in order to meet demand through late August....
Hyderabad based conglomerate INCOR Group and Renovis Labs, promoted by Prof. Javed Iqbal - country’s esteemed scientist, have entered into a new JV ‘INCOR Renovis’...
Pharma firm Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said....
AstraZeneca said two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the firm’s oncology portfolio...
, CDSCO.jpg)
